Roschier advised TA Associates on the offering. Elos Medtech completed a SEK 4.3 billion rights offering. The rights issue was fully underwritten by the principal shareholder...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here